home ver. 2.3. site index contact us

November 07, 2008
Schering-Plough to Webcast R&D Update Meeting
November 01, 2008
Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients
October 30, 2008
Schering-Plough to Appeal Jury Decision in Missouri Reimbursement Case
October 28, 2008
Sugammadex Study First to Show Rapid Reversal of Profound Rocuronium-Induced Muscle Relaxation is Possible
View all recent news items >


Compliance with U.S. Health Care Laws


California Compliance Declaration
>
 

At Schering-Plough we are proud of what we do - and of what we have accomplished in the past five years. Click here to read message.

Q3 2008 Earnings Press Release
Q3 2008 Earnings Webcast
Non-GAAP Reconciliation Tables
Earnings Results

 
                                      © 2003-2008 Schering-Plough Corporation.
                 Please see our legal notice, privacy policy and forward-looking statement.
Schering-Plough Schering-Plough skip to content Schering-Plough